312 related articles for article (PubMed ID: 17269692)
61. Stable hybridoma cultivation in a pilot-scale acoustic perfusion system: long-term process performance and effect of recirculation rate.
Dalm MC; Jansen M; Keijzer TM; van Grunsven WM; Oudshoorn A; Tramper J; Martens DE
Biotechnol Bioeng; 2005 Sep; 91(7):894-900. PubMed ID: 15959892
[TBL] [Abstract][Full Text] [Related]
62. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.
Heilmann K; Groth T; Behrsing O; Albrecht W; Schossig M; Lendlein A; Micheel B
J Biotechnol; 2005 Feb; 115(3):291-301. PubMed ID: 15639091
[TBL] [Abstract][Full Text] [Related]
63. Decreased pCO(2) accumulation by eliminating bicarbonate addition to high cell-density cultures.
Goudar CT; Matanguihan R; Long E; Cruz C; Zhang C; Piret JM; Konstantinov KB
Biotechnol Bioeng; 2007 Apr; 96(6):1107-17. PubMed ID: 17171711
[TBL] [Abstract][Full Text] [Related]
64. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
65. A simple kinetic model for myeloma cell culture with consideration of lysine limitation.
Liu YH; Bi JX; Zeng AP; Yuan JQ
Bioprocess Biosyst Eng; 2008 Oct; 31(6):569-77. PubMed ID: 18253755
[TBL] [Abstract][Full Text] [Related]
66. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
[TBL] [Abstract][Full Text] [Related]
67. Dynamic optimization of hybridoma growth in a fed-batch bioreactor.
Dhir S; Morrow KJ; Rhinehart RR; Wiesner T
Biotechnol Bioeng; 2000 Jan; 67(2):197-205. PubMed ID: 10592517
[TBL] [Abstract][Full Text] [Related]
68. Viable cell recycle with an inclined settler in the perfusion culture of suspended recombinant Chinese hamster ovary cells.
Searles JA; Todd P; Kompala DS
Biotechnol Prog; 1994; 10(2):198-206. PubMed ID: 7764677
[TBL] [Abstract][Full Text] [Related]
69. Efficiency improvement of an antibody production process by increasing the inoculum density.
Hecht V; Duvar S; Ziehr H; Burg J; Jockwer A
Biotechnol Prog; 2014; 30(3):607-15. PubMed ID: 24574274
[TBL] [Abstract][Full Text] [Related]
70. A sensitivity analysis of the fed-batch animal-cell bioreactor with respect to some control parameters.
Lavric V; Ofiţeru ID; Woinaroschy A
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):29-35. PubMed ID: 15270673
[TBL] [Abstract][Full Text] [Related]
71. Utility of an Escherichia coli strain engineered in the substrate uptake system for improved culture performance at high glucose and cell concentrations: an alternative to fed-batch cultures.
Lara AR; Caspeta L; Gosset G; Bolívar F; Ramírez OT
Biotechnol Bioeng; 2008 Mar; 99(4):893-901. PubMed ID: 17929322
[TBL] [Abstract][Full Text] [Related]
72. A semi-empirical mathematical model useful for describing the relationship between carbon dioxide, pH, lactate and base in a bicarbonate-buffered cell-culture process.
Gramer MJ; Ogorzalek T
Biotechnol Appl Biochem; 2007 Aug; 47(Pt 4):197-204. PubMed ID: 17362203
[TBL] [Abstract][Full Text] [Related]
73. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates.
Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL
J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552
[TBL] [Abstract][Full Text] [Related]
74. Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC.
Kanda Y; Yamane-Ohnuki N; Sakai N; Yamano K; Nakano R; Inoue M; Misaka H; Iida S; Wakitani M; Konno Y; Yano K; Shitara K; Hosoi S; Satoh M
Biotechnol Bioeng; 2006 Jul; 94(4):680-8. PubMed ID: 16609957
[TBL] [Abstract][Full Text] [Related]
75. An actively mixed mini-bioreactor for protein production from suspended animal cells.
Diao J; Young L; Zhou P; Shuler ML
Biotechnol Bioeng; 2008 May; 100(1):72-81. PubMed ID: 18078290
[TBL] [Abstract][Full Text] [Related]
76. An integrated process for mammalian cell perfusion cultivation and product purification using a dynamic filter.
Castilho LR; Anspach FB; Deckwer WD
Biotechnol Prog; 2002; 18(4):776-81. PubMed ID: 12153312
[TBL] [Abstract][Full Text] [Related]
77. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
Pollock J; Ho SV; Farid SS
Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
[TBL] [Abstract][Full Text] [Related]
78. CFD-aided cell settler design optimization and scale-up: effect of geometric design and operational variables on separation performance.
Shen Y; Yanagimachi K
Biotechnol Prog; 2011; 27(5):1282-96. PubMed ID: 21618723
[TBL] [Abstract][Full Text] [Related]
79. Optimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors.
Pohlscheidt M; Jacobs M; Wolf S; Thiele J; Jockwer A; Gabelsberger J; Jenzsch M; Tebbe H; Burg J
Biotechnol Prog; 2013; 29(1):222-9. PubMed ID: 23225663
[TBL] [Abstract][Full Text] [Related]
80. Scale-up and optimization of an acoustic filter for 200 L/day perfusion of a CHO cell culture.
Gorenflo VM; Smith L; Dedinsky B; Persson B; Piret JM
Biotechnol Bioeng; 2002 Nov; 80(4):438-44. PubMed ID: 12325152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
